Showing results (821-830 of 839) with videos related to

Sort By:
Pageof 84
Science (New York, N.Y.)|July 25, 2020
Simultaneous cross-evaluation of heterogeneous E. coli datasets via mechanistic simulationDerek N Macklin, Travis A Ahn-Horst, Heejo Choi, et al.
Blood|December 11, 2012
BCR-ABL1 compound mutations in tyrosine kinase inhibitor-resistant CML: frequency and clonal relationshipsJamshid S Khorashad, Todd W Kelley, Philippe Szankasi, et al.
British Journal of Haematology|December 1, 2022
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborativeZeinab Afify, Manuela Orjuela-Grimm, Christine Moore Smith, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|August 29, 2015
A mouse informatics platform for phenotypic and translational discoveryNatalie Ring, Terrence F Meehan, Andrew Blake, et al.
JAMA Oncology|August 19, 2021
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic LeukemiaDavid Spencer Mangum, Julia A Meyer, Clinton C Mason, et al.
Iscience|February 27, 2023
Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variantsIsabelle Montgomerie, Thomas W Bird, Olga R Palmer, et al.
Cancer|December 26, 2022
Multicenter study of pediatric Epstein-Barr virus-negative monomorphic post solid organ transplant lymphoproliferative disordersZeinab A M Afify, Mary M Taj, Manuela Orjuela-Grimm, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
European Heart Journal Open|October 18, 2021
Pericoronary and periaortic adipose tissue density are associated with inflammatory disease activity in Takayasu arteritis and atherosclerosisChristopher Wall, Yuan Huang, Elizabeth P V Le, et al.
Leukemia|August 20, 2014
Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemiaAnna M Eiring, Brent D G Page, Ira L Kraft, et al.
Pageof 84